Drugs / DCDS0780A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02453087 | Aug 2015 → Jul 2019 | B-cell non-Hodgkin lymphoma | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DCDS0780A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02453087 ↗ |
| Route | Intravenous | “DCDS0780A as intravenous infusion” NCT02453087 ↗ |